A team of scientists has mapped the regions surrounding stem cells in planarians—small flatworms that are famous for being ...

On October 21, 10x Genomics, Inc. and Prognosys Biosciences, Inc. filed a complaint for patent infringement against Illumina, ...

Cellarity has published a manuscript in Science describing its framework to integrate advanced transcriptomics and AI models for drug discovery.

SPT Labtech, and 10x Genomics, Inc. (Nasdaq: TXG), announced a strategic partnership to provide automated workflows for ...

One huge reason why the world of medicine hasn't yet found "the cure" for hard-to-treat malignancies like acute myeloid ...

Planarian stem cells can be “independent” and turn into any type of cell without needing a nearby niche, a new study indicates.

Biotech company 10x Genomics filed two lawsuits against rival Illumina in Delaware federal court on Tuesday, accusing ...

Genomics has administered a double dose of litigation to Illumina, joining with separate partners in a pair of federal lawsuits accusing the sequencing giant of infringing on nine patents related to ...

Cellarity, a biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and ...